Sisram Medical (SEHK:1696) - Cotización, noticias y análisis

Resumen de acción 1696

Sisram Medical Ltd se dedica a la investigación, diseño, desarrollo, fabricación y venta de equipos médicos de estética y odontología, dispositivos de uso doméstico, inyectables y productos cosmecéuticos en Asia-Pacífico, Europa, Norteamérica, Latinoamérica, Oriente Medio y África.

Acerca de la empresa

1696 fundamental analysis
Snowflake Score
Valuation	5/6
Future Growth	2/6
Past Performance	2/6
Financial Health	5/6
Dividends	3/6

Recompensas

Cotiza un 64% por debajo de nuestra estimación de su valor justo

Se prevé un crecimiento anual de los beneficios de 11.51%

Cotiza a buen valor en comparación con empresas similares e industria

Análisis de riesgos

Historial de dividendos inestable

Competidores de Sisram Medical Ltd

Acotec Scientific Holdings

SEHK:6669

HK$2.0b

PW Medtech Group

SEHK:1358

HK$1.5b

Gaush Meditech

SEHK:2407

HK$3.0b

MicroPort NeuroTech

SEHK:2172

HK$5.2b

Historial de precios y rendimiento

Summary of all time highs, changes and price drops for Sisram Medical
Historical stock prices
Current Share Price	HK$3.96
52 Week High	HK$11.74
52 Week Low	HK$2.96
Beta	1.45
1 Month Change	16.47%
3 Month Change	1.80%
1 Year Change	-65.92%
3 Year Change	-66.33%
5 Year Change	-14.29%
Change since IPO	-51.23%

Noticias y actualizaciones recientes

Returns On Capital At Sisram Medical (HKG:1696) Have Stalled

Apr 21

Does Sisram Medical (HKG:1696) Have A Healthy Balance Sheet?

Mar 28

Recent updates

Sisram Medical (HKG:1696) Shareholders Will Want The ROCE Trajectory To Continue

May 30

Is Sisram Medical (HKG:1696) Using Too Much Debt?

Apr 19

Is Now The Time To Look At Buying Sisram Medical Ltd (HKG:1696)?

Mar 01

Sisram Medical (HKG:1696) Could Be Struggling To Allocate Capital

Jan 12

Sisram Medical (HKG:1696) Has A Rock Solid Balance Sheet

Dec 21

Should You Investigate Sisram Medical Ltd (HKG:1696) At HK$7.99?

Dec 01

Some Investors May Be Worried About Sisram Medical's (HKG:1696) Returns On Capital

Oct 14

Here's Why We Think Sisram Medical (HKG:1696) Is Well Worth Watching

Sep 28

These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely

Aug 25

Should You Think About Buying Sisram Medical Ltd (HKG:1696) Now?

Aug 01

These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely

May 19

Is Sisram Medical Ltd (HKG:1696) Trading At A 29% Discount?

May 03

If You Like EPS Growth Then Check Out Sisram Medical (HKG:1696) Before It's Too Late

Apr 11

Sisram Medical (HKG:1696) Is Experiencing Growth In Returns On Capital

Mar 17

Is Now An Opportune Moment To Examine Sisram Medical Ltd (HKG:1696)?

Nov 22

Calculating The Intrinsic Value Of Sisram Medical Ltd (HKG:1696)

Aug 22

Be Wary Of Sisram Medical (HKG:1696) And Its Returns On Capital

Jul 27

Here's Why We Think Sisram Medical Ltd's (HKG:1696) CEO Compensation Looks Fair

Jun 24

Sisram Medical (HKG:1696) Could Be Struggling To Allocate Capital

Apr 16

Sisram Medical (HKG:1696) Has A Pretty Healthy Balance Sheet

Mar 26

Is Sisram Medical Ltd (HKG:1696) At Risk Of Cutting Its Dividend?

Mar 05

Sisram Medical (HKG:1696) Shareholders Booked A 79% Gain In The Last Year

Feb 12

Rentabilidad de los accionistas

	1696	HK Medical Equipment	Mercado HK
7D	11.9%	4.8%	2.2%
1Y	-65.9%	-45.4%	-7.9%

Rentabilidad vs. Industria: 1696 obtuvo unos resultados inferiores a los del sector Hong Kong Medical Equipment , que el año pasado arrojó un rendimiento del -48.4%.

Rentabilidad vs. Mercado: 1696 obtuvo unos resultados inferiores a los del mercado Hong Kong, que fue del -13.4% el año pasado.

Volatilidad de los precios

Is 1696's price volatile compared to industry and market?
1696 volatility
1696 Average Weekly Movement	7.3%
Medical Equipment Industry Average Movement	7.2%
Market Average Movement	7.5%
10% most volatile stocks in HK Market	14.9%
10% least volatile stocks in HK Market	3.7%

Precio estable de las acciones: 1696 no ha tenido una volatilidad de precios significativa en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de 1696 (8%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

Fundada	Empleados	CEO	Página web
2013	1,071	Lior Dayan	www.sisram-medical.com

Sisram Medical Ltd se dedica a la investigación, diseño, desarrollo, fabricación y venta de equipos médicos estéticos y dentales, dispositivos de uso doméstico, inyectables y productos cosmecéuticos en Asia-Pacífico, Europa, Norteamérica, Latinoamérica, Oriente Medio y África. Ofrece una cartera de productos y tratamientos para diversos sectores del bienestar, como depilación, rejuvenecimiento cutáneo, acné y cicatrices de acné, contorno corporal y facial, pigmentación y rejuvenecimiento cutáneo, injertos de grasa, rellenos faciales dérmicos, inyectables para remodelar el tejido cutáneo, cuidado personal y odontología estética, administración transepidérmica, tratamiento de la celulitis, estrías, lesiones vasculares y pigmentadas, hidradermoabrasión, blefaroplastia-estiramiento de párpados no quirúrgico, liposucción, salud femenina y rehabilitación sexual. La empresa también fabrica, distribuye y vende equipos médicos.

Resumen de fundamentos de Sisram Medical Ltd

¿Cómo se comparan los beneficios e ingresos de Sisram Medical con su capitalización de mercado?
Estadísticas fundamentales de 1696
Capitalización bursátil	HK$1.85b
Beneficios(TTM)	HK$246.05m
Ingresos (TTM)	HK$2.81b

7.5x

Ratio precio-beneficio (PE)

0.7x

Ratio precio-ventas (PS)

¿Está 1696 sobrevalorada?

Ver valor justo y análisis de valoración

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de 1696
Ingresos	US$359.29m
Coste de los ingresos	US$139.77m
Beneficio bruto	US$219.53m
Otros gastos	US$188.03m
Beneficios	US$31.50m

Últimos beneficios comunicados

Dec 31, 2023

Próxima fecha de beneficios

n/a

Beneficios por acción (BPA)	0.067
Margen bruto	61.10%
Margen de beneficio neto	8.77%
Ratio deuda/patrimonio	0.9%

¿Cómo se ha desempeñado 1696 a largo plazo?

Ver rendimiento histórico y comparativa

Dividendos

4.0%

Rentabilidad actual por dividendo

30%

Ratio de pagos

Resumen de acción 1696

Recompensas

Análisis de riesgos

Competidores de Sisram Medical Ltd

SEHK:6669

HK$2.0b

SEHK:1358

HK$1.5b

SEHK:2407

HK$3.0b

SEHK:2172

HK$5.2b

Historial de precios y rendimiento

Noticias y actualizaciones recientes

Full year 2023 earnings released: EPS: US$0.067 (vs US$0.086 in FY 2022)

Returns On Capital At Sisram Medical (HKG:1696) Have Stalled

Does Sisram Medical (HKG:1696) Have A Healthy Balance Sheet?

Full year 2023 earnings released: EPS: US$0.067 (vs US$0.086 in FY 2022)

Sisram Medical Ltd Announces Ordinary Final Cash Dividend for the Year Ended December 31, 2023

Sisram Medical Ltd to Report Fiscal Year 2023 Results on Mar 20, 2024

Recent updates

Full year 2023 earnings released: EPS: US$0.067 (vs US$0.086 in FY 2022)

Returns On Capital At Sisram Medical (HKG:1696) Have Stalled

Does Sisram Medical (HKG:1696) Have A Healthy Balance Sheet?

Full year 2023 earnings released: EPS: US$0.067 (vs US$0.086 in FY 2022)

Sisram Medical Ltd Announces Ordinary Final Cash Dividend for the Year Ended December 31, 2023

Sisram Medical Ltd to Report Fiscal Year 2023 Results on Mar 20, 2024

Estimating The Intrinsic Value Of Sisram Medical Ltd (HKG:1696)

Investor sentiment deteriorates as stock falls 20%

Now 21% overvalued

Take Care Before Diving Into The Deep End On Sisram Medical Ltd (HKG:1696)

Is Sisram Medical Ltd (HKG:1696) Potentially Undervalued?

Sisram Medical Ltd Announces the Registration Application of Profhilo

Is Sisram Medical (HKG:1696) Using Too Much Debt?

Investor sentiment improves as stock rises 19%

Returns On Capital At Sisram Medical (HKG:1696) Have Stalled

At HK$6.71, Is It Time To Put Sisram Medical Ltd (HKG:1696) On Your Watch List?

First half 2023 earnings released: EPS: US$0.04 (vs US$0.044 in 1H 2022)

Upcoming dividend of HK$0.17 per share at 2.3% yield

Sisram Medical (HKG:1696) Is Paying Out A Larger Dividend Than Last Year

Sisram Medical Ltd Announces Final Ordinary Dividend for the Year Ended December 31, 2022, Payable 07 September 2023

Sisram Medical Announces the Launch of Alma Veil for the U.S. Market

Sisram Medical Ltd. Receives the Clearance from the U.S. Food and Drug Administration

Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?

Investor sentiment improves as stock rises 16%

Sisram Medical (HKG:1696) Shareholders Will Want The ROCE Trajectory To Continue

Sisram Medical Ltd, Annual General Meeting, Jun 28, 2023

Is Sisram Medical (HKG:1696) Using Too Much Debt?

Investor sentiment improves as stock rises 18%

Full year 2022 earnings released: EPS: US$0.086 (vs US$0.069 in FY 2021)

Investor sentiment deteriorates as stock falls 16%

Is Now The Time To Look At Buying Sisram Medical Ltd (HKG:1696)?

Investor sentiment improves as stock rises 18%

Investor sentiment improves as stock rises 19%

Sisram Medical (HKG:1696) Could Be Struggling To Allocate Capital

Sisram Medical Ltd Announces Resignation of Mr. Guojun Bu from the Position of Executive Director of the Company with Effect from January 1, 2023

Investor sentiment improved over the past week

Sisram Medical (HKG:1696) Has A Rock Solid Balance Sheet

Investor sentiment improved over the past week

Should You Investigate Sisram Medical Ltd (HKG:1696) At HK$7.99?

Less than half of directors are independent

Investor sentiment improved over the past week

Some Investors May Be Worried About Sisram Medical's (HKG:1696) Returns On Capital

Investor sentiment deteriorated over the past week

Here's Why We Think Sisram Medical (HKG:1696) Is Well Worth Watching

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely

Sisram Medical Ltd Provides Revenue Guidance for the Year 2022

First half 2022 earnings released: EPS: US$0.044 (vs US$0.037 in 1H 2021)

Sisram Medical Ltd SHARE to Be Deleted from OTC Equity

Upcoming dividend of HK$0.16 per share

Sisram Medical Ltd to Report Q2, 2022 Results on Aug 19, 2022

Sisram Medical Ltd Declares Final Dividend for the Year Ended December 31, 2021, Payable on or Around 2 September 2022

Should You Think About Buying Sisram Medical Ltd (HKG:1696) Now?

Investor sentiment deteriorated over the past week

Sisram Medical Ltd Announces Phase IIb Clinical Result on Submental Fat Reduction of JS-001

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Sisram Medical Ltd Announces Resignation of Yao WANG as Non-Executive Director